The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 11.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 51% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855.
KLA Corporation
KLAC · a US exchange · USD · Market cap $24.0B · 15,000 employees
KLA Corporation, together with its subsidiaries, designs, manufactures, and markets process control, process-enabling, and yield management solutions for the semiconductor and related electronics industries worldwide.
FAIL · Does not pass the screenScreen close, 2026-09-21 · not a live quote
Screened 2026-09-21 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 183.97 against the desk's fair-value range, base estimate 145.26, over the last year.
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
KLA Corporation holds its Distribution at $183.97. Consolidating, no directional conviction, held for 58 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 58 days |
| Price at the screen | $183.97 |
| Valuation | 50.27 trailing · 27.50 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.44 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 37.89% | Below 33% | Interest-bearing debt is 37.9% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 15.03% | Below 33% | Cash held in interest-bearing accounts and securities is 15.0% of assets, under the one-third limit. | Pass |
| Receivables | 27.03% | Below 49% | Money owed to the company is 27.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.48% | Below 5% | Only 1.5% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $145.26 fair value estimate, strong competitive moat, 15.20% revenue growth.
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. The price runs 21.0% above the base estimate.
Third-party analyst targets: 26 covering, consensus Buy. The average target sits +27% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsKLA Corporation - An Overvalued Semiconductor Cyclical
Imagine a global factory floor where every new chip is birthed, KLA Corporation is the company supplying the tools to smooth out that process. Operating in the cyclical semiconductor space, they design and market process control and yield management solutions, essential for the electronics industry's rapid innovation. Why it stands out, or rather why we're cautious, is due to its valuation. At a price of $185.86, the market cap far exceeds our fair value of $142.90, indicating a significant overvaluation.
Despite robust revenue growth of 15% and a strong profit margin of 36%, KLA Corporation fails our ethical screen due to its debt ratio. This, coupled with the industry's cyclical nature and the stock's high forward P/E of 28.1x, suggests we could be looking at a peak earnings, low multiple trap—a warning sign in cyclical industries rather than a bargain. The market's consensus buy rating and lofty median target of $230 seem detached from these underlying risks.
Risk sits around the cyclical nature of semiconductors and the company's debt levels. KLA Corporation, though a leader in its field, is not immune to the industry's boom-and-bust cycles, and its ethical failing on debt further compounds the caution needed. Analysis, not advice.
| Forward P/E | 27.5xpriced for continued growth |
| Trailing P/E | 50.3xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 3.66 |
| EPS, forward | 6.69 |
| Revenue growth | +15.2%steady growth |
| Profit margin | 35.6%highly profitable on every dollar of sales |
| Return on equity | 87.5%an exceptional return on shareholder capital |
| FCF yield | 1.06% |
| Dividend yield | 49.00% |
| Debt to equity | 0.97moderate, manageable leverage |
| Current ratio | 2.88comfortably covers its short-term bills |
| Beta | 1.44moves a little more than the market |
| Short interest, float | 0.02% |
| 52-week range | 91.02 - 307.37 |
| Moat | STRONG |
| Market cap | $24.0B |
| Employees | 15,000 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeKLAC trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 51% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 51% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 51% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 51% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 51% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 51% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 89.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 51% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 51% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 152%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (29 analysts) rates it buy, with a mean price target of $1855.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Better Artificial Intelligence Stock: Aehr Test Systems vs. KLA Corporation Motley Fool · 3d ago
- Chip Stocks Break Through Ceiling As Sector Rebounds. Macom Is A Standout. Investor's Business Daily · 4d ago
- KLAC Gains From AI Infrastructure: Can It Outpace AMAT & ASML? Zacks · 4d ago
- Lam Research Climbs 5% as Chip Equipment Names Outrun the Sector; Applied Materials Rises 4%, KLA Corp. Gains 3% 24/7 Wall St. · 4d ago
- Eisman Says Buy Micron And SK Hynix. “In This Knife Fight You Want To Be The One Selling The Knives” 24/7 Wall St. · 4d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-12 | WALLACE RICHARD P | Chief Executive Officer | 4,512 | $8,094,528 | |
| 2026-05-11 | HANLEY JENEANNE MICHELLE | Director | 550 | $1,031,088 | |
| 2026-05-11 | KIRLOSKAR VIRENDRA A | Officer | 297 | $558,069 | |
| 2026-02-05 | CALDERONI ROBERT M | Director | 11 | · | |
| 2025-12-16 | HIGGINS BREN D. | Chief Financial Officer | 2,254 | $2,788,221 | |
| 2025-11-12 | KHAN AHMAD A | Officer | 85 | · | |
| 2025-11-11 | WALLACE RICHARD P | Chief Executive Officer | 804 | · | |
| 2025-11-11 | WALLACE RICHARD P | Chief Executive Officer | 10,803 | $12,997,089 | |
| 2025-11-05 | CALDERONI ROBERT M | Director | 256 | · | |
| 2025-11-05 | SAMATH JAMIE E. | Director | 203 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-07-01 | Michael Rulli | Republican | buy | 1K–15K |
| 2024-05-03 | Tommy Tuberville | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1,842.84 | +16.4% | $2.30 | $1,166 | +16.6% |
| 2 months | $1,735.07 | +23.7% | $2.30 | $1,238 | +23.8% |
| 3 months | $1,407.77 | +52.4% | $2.30 | $1,526 | +52.6% |
| 6 months | $1,242.98 | +72.6% | $4.20 | $1,730 | +73.0% |
| 1 year | $851.10 | +152.1% | $8.00 | $2,531 | +153.1% |
| 2 years | $782.02 | +174.4% | $14.75 | $2,763 | +176.3% |
| 3 years | $453.97 | +372.7% | $20.40 | $4,772 | +377.2% |
| 5 years | $304.29 | +605.2% | $29.80 | $7,150 | +615.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever KLAC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.